All Studies Meta Analysis

Calcitriol, the active form of vitamin D, is a promising candidate for COVID-19 prophylaxis

Mok et al., bioRxiv, doi:10.1101/2020.06.21.162396

Jun 2020

Post
Facebook

Source PDF All Studies Meta AnalysisMeta

Vitamin D for COVID-19

8th treatment shown to reduce risk in October 2020, now with p < 0.00000000001 from 122 studies, recognized in 9 countries.

Lower risk for mortality, ICU admission, hospitalization, progression, recovery, cases, and viral clearance.

No treatment is 100% effective. Protocols combine treatments.

5,100+ studies for 109 treatments. c19early.org

In Vitro study showing that the active form of Vitamin D, calcitriol, exhibits significant potent activity against SARS-CoV-2.

21 preclinical studies support the efficacy of vitamin D for COVID-19:

7 In Silico studies1-7

11 In Vitro studies8-18

3 In Vivo animal studies10,14,19

Vitamin D has been identified by the European Food Safety Authority (EFSA) as having sufficient evidence for a causal relationship between intake and optimal immune system function20-23. Vitamin D inhibits SARS-CoV-2 replication in vitro10,17, mitigates lung inflammation, damage, and lethality in mice with an MHV-3 model for β-CoV respiratory infections10,17, reduces SARS-CoV-2 replication in nasal epithelial cells via increased type I interferon expression13, downregulates proinflammatory cytokines IL-1β and TNF-α in SARS-CoV-2 spike protein-stimulated cells9, attenuates nucleocapsid protein-induced hyperinflammation by inactivating the NLRP3 inflammasome through the VDR-BRCC3 signaling pathway14, may be neuroprotective by protecting the blood-brain barrier, reducing neuroinflammation, and via immunomodulatory effects24, downregulates ACE2 and TMPRSS2 in human trophoblasts and minimizes spike protein-induced inflammation12, minimizes platelet aggregation mediated by SARS-CoV-2 spike protein via inhibiting integrin αIIbβ3 outside-in signaling8, and improves regulatory immune cell levels and control of proinflammatory cytokines in severe COVID-1925. Symptomatic COVID-19 is associated with a lower frequency of natural killer (NK) cells and vitamin D has been shown to improve NK cell activity26,27.

Important missing comments or errors? Let us know.

1. Morales-Bayuelo et al., New findings on ligand series used as SARS-CoV-2 virus inhibitors within the frameworks of molecular docking, molecular quantum similarity and chemical reactivity indices, F1000Research, doi:10.12688/f1000research.123550.3.f1000research.com, doi.org.

2. Chellasamy et al., Docking and molecular dynamics studies of human ezrin protein with a modelled SARS-CoV-2 endodomain and their interaction with potential invasion inhibitors, Journal of King Saud University - Science, doi:10.1016/j.jksus.2022.102277.sciencedirect.com, doi.org.

3. Pandya et al., Unravelling Vitamin B12 as a potential inhibitor against SARS-CoV-2: A computational approach, Informatics in Medicine Unlocked, doi:10.1016/j.imu.2022.100951.sciencedirect.com, doi.org.

4. Mansouri et al., The impact of calcitriol and estradiol on the SARS-CoV-2 biological activity: a molecular modeling approach, Scientific Reports, doi:10.1038/s41598-022-04778-y.nature.com, doi.org.

5. Song et al., Vitamin D3 and its hydroxyderivatives as promising drugs against COVID-19: a computational study, Journal of Biomolecular Structure and Dynamics, doi:10.1080/07391102.2021.1964601.tandfonline.com, doi.org.

6. Qayyum et al., Vitamin D and lumisterol novel metabolites can inhibit SARS-CoV-2 replication machinery enzymes, Endocrinology and Metabolism, doi:10.1152/ajpendo.00174.2021.physiology.org, doi.org.

7. Al-Mazaideh et al., Vitamin D is a New Promising Inhibitor to the Main Protease (Mpro) of COVID-19 by Molecular Docking, Journal of Pharmaceutical Research International, doi:10.9734/jpri/2021/v33i29B31603.journaljpri.com, doi.org.

8. Wang et al., 1,25‐Dihydroxyvitamin D3 attenuates platelet aggregation potentiated by SARS‐CoV‐2 spike protein via inhibiting integrin αIIbβ3 outside‐in signaling, Cell Biochemistry and Function, doi:10.1002/cbf.4039.wiley.com, doi.org.

9. Alcalá-Santiago et al., Disentangling the Immunomodulatory Effects of Vitamin D on the SARS-CoV-2 Virus by In Vitro Approaches, The 14th European Nutrition Conference FENS 2023, doi:10.3390/proceedings2023091415.mdpi.com, doi.org.

10. Campolina-Silva et al., Dietary Vitamin D Mitigates Coronavirus-Induced Lung Inflammation and Damage in Mice, Viruses, doi:10.3390/v15122434.mdpi.com, doi.org.

11. Moatasim et al., Potent Antiviral Activity of Vitamin B12 against Severe Acute Respiratory Syndrome Coronavirus 2, Middle East Respiratory Syndrome Coronavirus, and Human Coronavirus 229E, Microorganisms, doi:10.3390/microorganisms11112777.mdpi.com, doi.org.

12. Vargas-Castro et al., Calcitriol prevents SARS-CoV spike-induced inflammation in human trophoblasts through downregulating ACE2 and TMPRSS2 expression, The Journal of Steroid Biochemistry and Molecular Biology, doi:10.1016/j.jsbmb.2024.106625.sciencedirect.com, doi.org.

13. Sposito et al., Age differential CD13 and interferon expression in airway epithelia affect SARS-CoV-2 infection - effects of vitamin D, Mucosal Immunology, doi:10.1016/j.mucimm.2023.08.002.nih.gov, doi.org.

14. Chen et al., Vitamin D3 attenuates SARS‐CoV‐2 nucleocapsid protein‐caused hyperinflammation by inactivating the NLRP3 inflammasome through the VDR‐BRCC3 signaling pathway in vitro and in vivo, MedComm, doi:10.1002/mco2.318.wiley.com, doi.org.

15. Rybakovsky et al., Calcitriol modifies tight junctions, improves barrier function, and reduces TNF‐α‐induced barrier leak in the human lung‐derived epithelial cell culture model, 16HBE 14o‐, Physiological Reports, doi:10.14814/phy2.15592.wiley.com, doi.org.

16. DiGuilio et al., The multiphasic TNF-α-induced compromise of Calu-3 airway epithelial barrier function, Experimental Lung Research, doi:10.1080/01902148.2023.2193637.tandfonline.com, doi.org.

17. Pickard et al., Discovery of re-purposed drugs that slow SARS-CoV-2 replication in human cells, PLOS Pathogens, doi:10.1371/journal.ppat.1009840.plos.org, doi.org.

18. Mok et al., Calcitriol, the active form of vitamin D, is a promising candidate for COVID-19 prophylaxis, bioRxiv, doi:10.1101/2020.06.21.162396.biorxiv.org, doi.org.

19. Fernandes de Souza et al., Lung Inflammation Induced by Inactivated SARS-CoV-2 in C57BL/6 Female Mice Is Controlled by Intranasal Instillation of Vitamin D, Cells, doi:10.3390/cells12071092.mdpi.com, doi.org.

20. Galmés et al., Suboptimal Consumption of Relevant Immune System Micronutrients Is Associated with a Worse Impact of COVID-19 in Spanish Populations, Nutrients, doi:10.3390/nu14112254.mdpi.com, doi.org.

21. Galmés (B) et al., Current State of Evidence: Influence of Nutritional and Nutrigenetic Factors on Immunity in the COVID-19 Pandemic Framework, Nutrients, doi:10.3390/nu12092738.mdpi.com, doi.org.

22. EFSA, Scientific Opinion on the substantiation of a health claim related to vitamin D and contribution to the normal function of the immune system pursuant to Article 14 of Regulation (EC) No 1924/2006, EFSA Journal, doi:10.2903/j.efsa.2015.4096.europa.eu, doi.org.

23. EFSA (B), Scientific Opinion on the substantiation of health claims related to vitamin D and normal function of the immune system and inflammatory response (ID 154, 159), maintenance of normal muscle function (ID 155) and maintenance of normal cardiovascular function (ID 159) pursuant to Article 13(1) of Regulation (E, EFSA Journal, doi:10.2903/j.efsa.2010.1468.wiley.com, doi.org.

24. Gotelli et al., Understanding the immune-endocrine effects of vitamin D in SARS-CoV-2 infection: a role in protecting against neurodamage?, Neuroimmunomodulation, doi:10.1159/000533286.karger.com, doi.org.

25. Saheb Sharif-Askari et al., Increased blood immune regulatory cells in severe COVID-19 with autoantibodies to type I interferons, Scientific Reports, doi:10.1038/s41598-023-43675-w.nature.com, doi.org.

26. Graydon et al., High baseline frequencies of natural killer cells are associated with asymptomatic SARS-CoV-2 infection, Current Research in Immunology, doi:10.1016/j.crimmu.2023.100064.sciencedirect.com, doi.org.

27. Oh et al., Vitamin D and Exercise Are Major Determinants of Natural Killer Cell Activity, Which Is Age- and Gender-Specific, Frontiers in Immunology, doi:10.3389/fimmu.2021.594356.frontiersin.org, doi.org.

Mok et al., 22 Jun 2020, preprint, 20 authors.

In Vitro studies are an important part of preclinical research, however results may be very different in vivo.

This Paper Vitamin D All

Calcitriol, the active form of vitamin D, is a promising candidate for COVID-19 prophylaxis

Chee Keng Mok, Yan Ling Ng, Bintou Ahmadou Ahidjo, Regina Ching Hua Lee, Marcus Wing Choy Loe, Jing Liu, Kai Sen Tan, Parveen Kaur, Wee Joo Chng, John Eu-Li Wong, De Yun Wang, Erwei Hao, Xiaotao Hou, Yong Wah Tan, Tze Minn Mak, Cui Lin, Raymond Lin, Paul Tambyah, Jiagang Deng, Justin Jang Hann Chu

doi:10.1101/2020.06.21.162396

, the disease caused by SARS-CoV-2 (1), was declared a pandemic by the World Health Organization (WHO) in March 2020 (2). While awaiting a vaccine, several antivirals are being used to manage the disease with limited success (3, 4). To expand this arsenal, we screened 4 compound libraries: a United States Food and Drug Administration (FDA) approved drug library, an angiotensin converting enzyme-2 (ACE2) targeted compound library, a flavonoid compound library as well as a natural product library. Of the 121 compounds identified with activity against SARS-CoV-2, 7 were shortlisted for validation. We show for the first time that the active form of Vitamin D, calcitriol, exhibits significant potent activity against SARS-CoV-2. This finding paves the way for consideration of host-directed therapies for ring prophylaxis of contacts of SARS-CoV-2 patients.

Author contributions Conceived and designed the experiments: CKM, JJHC. Performed the experiments: CKM, YLN, BAA, RCHL. Analyzed the data: CKM, YLN, BAA, RCHL, MWCL, PK, PT, WJC, JEW, JJHC. Contributed reagents/materials: JL, KST, DYW, EH, XH JD, TMM, CL, RL. Wrote the paper: BAA, MWCL, YLN, RCHL, PK, CKM, YWT, JJHC. All the authors read the manuscript and approved it before submission

References

Ahidjo, Loe, Ng, Mok, Jjh, Current Perspective of Antiviral Strategies against COVID-19, ACS Infect Dis

Balicer, Huerta, Grotto, Tackling the next influenza pandemic, BMJ

Barnard, Hubbard, Burton, Smee, Morrey et al., Inhibition of severe acute respiratory syndrome-associated coronavirus (SARSCoV) by calpain inhibitors and beta-D-N4-hydroxycytidine, Antivir Chem Chemother

Dyall, Coleman, Hart, Venkataraman, Holbrook et al., Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection, Antimicrob Agents Chemother

Fajgenbaum, Khor, Gorzewski, Tamakloe, Powers et al., Treatments Administered to the First 9152 Reported Cases of COVID-19: A Systematic Review, Infect Dis Ther

Freymuth, Vabret, Rozenberg, Dina, Petitjean et al., Replication of respiratory viruses, particularly influenza virus, rhinovirus, and coronavirus in HuH7 hepatocarcinoma cell line, J Med Virol

Gombart, The vitamin D-antimicrobial peptide pathway and its role in protection against infection, Future Microbiol

Grant, Lahore, Mcdonnell, Baggerly, French et al., Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths, Nutrients

Ilie, Stefanescu, Smith, The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality, Aging Clin Exp Res

Nair, Vitamin d deficiency and liver disease, Gastroenterology & hepatology

Nie, Wang, Shi, Wang, Chen et al., Highly infectious SARS-CoV pseudotyped virus reveals the cell tropism and its correlation with receptor expression, Biochem Biophys Res Commun

Rodriguez, Munoz-Castaneda, Almaden, Therapeutic use of calcitriol, Current vascular pharmacology

Sungnak, Huang, Becavin, Berg, Queen et al., SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes, Nat Med

Tu, Chien, Yarmishyn, Lin, Luo et al., A Review of SARS-CoV-2 and the Ongoing Clinical Trials, Int J Mol Sci

Van Genugten, Heijnen, Jager, Pandemic influenza and healthcare demand in the Netherlands: scenario analysis, Emerg Infect Dis

Wei, Li, Chiew, Yong, Toh et al., Presymptomatic Transmission of SARS-CoV-2 -Singapore, January 23, MMWR Morb Mortal Wkly Rep

Who, Rolling updates on coronavirus disease (COVID-19

Yan, Liu, Zhu, Huang, Dan et al., Factors associated with prolonged viral shedding and impact of Lopinavir/Ritonavir treatment in hospitalised noncritically ill patients with SARS-CoV-2 infection, Eur Respir J

Yan, Tan, Li, Tran, Chao et al., Human nasal epithelial cells derived from multiple subjects exhibit differential responses to H3N2 influenza virus infection in vitro, J Allergy Clin Immunol

Zhao, Yu, Li, Li, Chao et al., The use of nasal epithelial stem/progenitor cells to produce functioning ciliated cells in vitro, Am J Rhinol Allergy

Zhou, Yang, Wang, Hu, Zhang et al., A pneumonia outbreak associated with a new coronavirus of probable bat origin, Nature

{ 'institution': [{'name': 'bioRxiv'}], 'indexed': {'date-parts': [[2024, 4, 28]], 'date-time': '2024-04-28T01:55:00Z', 'timestamp': 1714269300010}, 'posted': {'date-parts': [[2020, 6, 22]]}, 'group-title': 'Microbiology', 'reference-count': 25, 'publisher': 'Cold Spring Harbor Laboratory', 'content-domain': {'domain': [], 'crossmark-restriction': False}, 'accepted': {'date-parts': [[2020, 6, 22]]}, 'abstract': 'AbstractCOVID-19, the disease caused by SARS-CoV-2 (1), was ' 'declared a pandemic by the World Health Organization (WHO) in March 2020 (2). While awaiting ' 'a vaccine, several antivirals are being used to manage the disease with limited success (3, ' '4). To expand this arsenal, we screened 4 compound libraries: a United States Food and Drug ' 'Administration (FDA) approved drug library, an angiotensin converting enzyme-2 (ACE2) ' 'targeted compound library, a flavonoid compound library as well as a natural product library. ' 'Of the 121 compounds identified with activity against SARS-CoV-2, 7 were shortlisted for ' 'validation. We show for the first time that the active form of Vitamin D, calcitriol, ' 'exhibits significant potent activity against SARS-CoV-2. This finding paves the way for ' 'consideration of host-directed therapies for ring prophylaxis of contacts of SARS-CoV-2 ' 'patients.', 'DOI': '10.1101/2020.06.21.162396', 'type': 'posted-content', 'created': {'date-parts': [[2020, 6, 23]], 'date-time': '2020-06-23T08:59:45Z', 'timestamp': 1592902785000}, 'source': 'Crossref', 'is-referenced-by-count': 36, 'title': 'Calcitriol, the active form of vitamin D, is a promising candidate for COVID-19 prophylaxis', 'prefix': '10.1101', 'author': [ {'given': 'Chee Keng', 'family': 'Mok', 'sequence': 'first', 'affiliation': []}, {'given': 'Yan Ling', 'family': 'Ng', 'sequence': 'additional', 'affiliation': []}, {'given': 'Bintou Ahmadou', 'family': 'Ahidjo', 'sequence': 'additional', 'affiliation': []}, {'given': 'Regina Ching', 'family': 'Hua Lee', 'sequence': 'additional', 'affiliation': []}, {'given': 'Marcus Wing', 'family': 'Choy Loe', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jing', 'family': 'Liu', 'sequence': 'additional', 'affiliation': []}, {'given': 'Kai Sen', 'family': 'Tan', 'sequence': 'additional', 'affiliation': []}, {'given': 'Parveen', 'family': 'Kaur', 'sequence': 'additional', 'affiliation': []}, {'given': 'Wee Joo', 'family': 'Chng', 'sequence': 'additional', 'affiliation': []}, {'given': 'John Eu-Li', 'family': 'Wong', 'sequence': 'additional', 'affiliation': []}, {'given': 'De Yun', 'family': 'Wang', 'sequence': 'additional', 'affiliation': []}, {'given': 'Erwei', 'family': 'Hao', 'sequence': 'additional', 'affiliation': []}, {'given': 'Xiaotao', 'family': 'Hou', 'sequence': 'additional', 'affiliation': []}, {'given': 'Yong Wah', 'family': 'Tan', 'sequence': 'additional', 'affiliation': []}, {'given': 'Tze Minn', 'family': 'Mak', 'sequence': 'additional', 'affiliation': []}, {'given': 'Cui', 'family': 'Lin', 'sequence': 'additional', 'affiliation': []}, {'given': 'Raymond', 'family': 'Lin', 'sequence': 'additional', 'affiliation': []}, {'given': 'Paul', 'family': 'Tambyah', 'sequence': 'additional', 'affiliation': []}, {'given': 'JiaGang', 'family': 'Deng', 'sequence': 'additional', 'affiliation': []}, {'given': 'Justin Jang', 'family': 'Hann Chu', 'sequence': 'additional', 'affiliation': []}], 'member': '246', 'reference': [ { 'key': '2020062508250630000_2020.06.21.162396v1.1', 'doi-asserted-by': 'publisher', 'DOI': '10.1038/s41564-020-0695-z'}, { 'key': '2020062508250630000_2020.06.21.162396v1.2', 'unstructured': 'WHO. Rolling updates on coronavirus disease (COVID-19). ' 'https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen. ' 'Accessed 8 June 2020.'}, { 'key': '2020062508250630000_2020.06.21.162396v1.3', 'doi-asserted-by': 'crossref', 'unstructured': 'Fajgenbaum DC , Khor JS , Gorzewski A , Tamakloe MA , Powers V , Kakkis ' 'JJ , et al. Treatments Administered to the First 9152 Reported Cases of ' 'COVID-19: A Systematic Review. Infect Dis Ther. 2020.', 'DOI': '10.1007/s40121-020-00303-8'}, { 'key': '2020062508250630000_2020.06.21.162396v1.4', 'doi-asserted-by': 'crossref', 'unstructured': 'Ahidjo BA , Loe M , Ng YL , Mok CK , and Chu JJH . Current Perspective ' 'of Antiviral Strategies against COVID-19. ACS Infect Dis. 2020.', 'DOI': '10.1021/acsinfecdis.0c00236'}, { 'key': '2020062508250630000_2020.06.21.162396v1.5', 'doi-asserted-by': 'publisher', 'DOI': '10.1136/bmj.328.7453.1391'}, { 'key': '2020062508250630000_2020.06.21.162396v1.6', 'doi-asserted-by': 'publisher', 'DOI': '10.1038/s41586-020-2012-7'}, { 'key': '2020062508250630000_2020.06.21.162396v1.7', 'doi-asserted-by': 'publisher', 'DOI': '10.1128/AAC.03036-14'}, { 'key': '2020062508250630000_2020.06.21.162396v1.8', 'doi-asserted-by': 'crossref', 'unstructured': 'Yan D , Liu XY , Zhu YN , Huang L , Dan BT , Zhang GJ , et al. Factors ' 'associated with prolonged viral shedding and impact of ' 'Lopinavir/Ritonavir treatment in hospitalised non-critically ill ' 'patients with SARS-CoV-2 infection. Eur Respir J. 2020.', 'DOI': '10.1183/13993003.00799-2020'}, { 'key': '2020062508250630000_2020.06.21.162396v1.9', 'doi-asserted-by': 'publisher', 'DOI': '10.1177/095632020401500102'}, { 'key': '2020062508250630000_2020.06.21.162396v1.10', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.bbrc.2004.07.060'}, { 'key': '2020062508250630000_2020.06.21.162396v1.11', 'doi-asserted-by': 'publisher', 'DOI': '10.1002/jmv.20449'}, { 'issue': '5', 'key': '2020062508250630000_2020.06.21.162396v1.12', 'doi-asserted-by': 'crossref', 'first-page': '681', 'DOI': '10.1038/s41591-020-0868-6', 'article-title': 'SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells ' 'together with innate immune genes', 'volume': '26', 'year': '2020', 'journal-title': 'Nat Med'}, { 'key': '2020062508250630000_2020.06.21.162396v1.13', 'doi-asserted-by': 'crossref', 'unstructured': 'Ilie PC , Stefanescu S , and Smith L. The role of vitamin D in the ' 'prevention of coronavirus disease 2019 infection and mortality. Aging ' 'Clin Exp Res. 2020:1–4.', 'DOI': '10.21203/rs.3.rs-21211/v1'}, { 'key': '2020062508250630000_2020.06.21.162396v1.14', 'doi-asserted-by': 'crossref', 'unstructured': 'Grant WB , Lahore H , McDonnell SL , Baggerly CA , French CB , Aliano JL ' ', et al. Evidence that Vitamin D Supplementation Could Reduce Risk of ' 'Influenza and COVID-19 Infections and Deaths. Nutrients. 2020;12(4).', 'DOI': '10.3390/nu12040988'}, { 'key': '2020062508250630000_2020.06.21.162396v1.15', 'doi-asserted-by': 'publisher', 'DOI': '10.2217/fmb.09.87'}, { 'key': '2020062508250630000_2020.06.21.162396v1.16', 'doi-asserted-by': 'crossref', 'unstructured': 'Ilie PC , Stefanescu S , and Smith L. The role of vitamin D in the ' 'prevention of coronavirus disease 2019 infection and mortality. Aging ' 'Clin Exp Res. 2020.', 'DOI': '10.21203/rs.3.rs-21211/v1'}, { 'key': '2020062508250630000_2020.06.21.162396v1.17', 'unstructured': 'ClinicalTrials.gov. ' 'https://clinicaltrials.gov/ct2/results/browse?cond=COVID-19&term=&cntry=&state=&city=&dist=&Search=Search&brwse=cond_alpha_all&type=Intr. ' 'Accessed 21 April 2020.'}, { 'key': '2020062508250630000_2020.06.21.162396v1.18', 'doi-asserted-by': 'crossref', 'unstructured': 'Tu YF , Chien CS , Yarmishyn AA , Lin YY , Luo YH , Lin YT , et al. A ' 'Review of SARS-CoV-2 and the Ongoing Clinical Trials. Int J Mol Sci. ' '2020;21.', 'DOI': '10.3390/ijms21072657'}, { 'key': '2020062508250630000_2020.06.21.162396v1.19', 'unstructured': 'WHO. Geneva: World Health Organisation; 2020.'}, { 'key': '2020062508250630000_2020.06.21.162396v1.20', 'doi-asserted-by': 'publisher', 'DOI': '10.3201/eid0905.020321'}, { 'issue': '8', 'key': '2020062508250630000_2020.06.21.162396v1.21', 'first-page': '491', 'article-title': 'Vitamin d deficiency and liver disease', 'volume': '6', 'year': '2010', 'journal-title': 'Gastroenterology & hepatology'}, { 'issue': '2', 'key': '2020062508250630000_2020.06.21.162396v1.22', 'doi-asserted-by': 'crossref', 'first-page': '294', 'DOI': '10.2174/15701611113119990021', 'article-title': 'Therapeutic use of calcitriol', 'volume': '12', 'year': '2014', 'journal-title': 'Current vascular pharmacology'}, { 'key': '2020062508250630000_2020.06.21.162396v1.23', 'doi-asserted-by': 'publisher', 'DOI': '10.15585/mmwr.mm6914e1'}, { 'issue': '1', 'key': '2020062508250630000_2020.06.21.162396v1.24', 'doi-asserted-by': 'crossref', 'first-page': '276', 'DOI': '10.1016/j.jaci.2015.11.016', 'article-title': 'Human nasal epithelial cells derived from multiple subjects exhibit ' 'differential responses to H3N2 influenza virus infection in vitro', 'volume': '138', 'year': '2016', 'journal-title': 'J Allergy Clin Immunol'}, { 'issue': '5', 'key': '2020062508250630000_2020.06.21.162396v1.25', 'doi-asserted-by': 'crossref', 'first-page': '345', 'DOI': '10.2500/ajra.2012.26.3794', 'article-title': 'The use of nasal epithelial stem/progenitor cells to produce ' 'functioning ciliated cells in vitro', 'volume': '26', 'year': '2012', 'journal-title': 'Am J Rhinol Allergy'}], 'container-title': [], 'original-title': [], 'link': [ { 'URL': 'https://syndication.highwire.org/content/doi/10.1101/2020.06.21.162396', 'content-type': 'unspecified', 'content-version': 'vor', 'intended-application': 'similarity-checking'}], 'deposited': { 'date-parts': [[2020, 6, 25]], 'date-time': '2020-06-25T15:25:20Z', 'timestamp': 1593098720000}, 'score': 1, 'resource': {'primary': {'URL': 'http://biorxiv.org/lookup/doi/10.1101/2020.06.21.162396'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2020, 6, 22]]}, 'references-count': 25, 'URL': 'http://dx.doi.org/10.1101/2020.06.21.162396', 'relation': {}, 'subject': [], 'published': {'date-parts': [[2020, 6, 22]]}, 'subtype': 'preprint'}

Download Image

Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.

Submit

Post

@CovidAnalysis

FAQ

Public domain CC0 1.0